IAVI, Merck, and Serum Institute of India to develop monoclonal antibodies for Covid
New Delhi, Oct 22 : IAVI, a non-profit scientific research organisation and Serum Institute of India announced an agreement with Merck to develop SARS-CoV-2 neutralising monoclonal antibodies (mAbs) co-invented by IAVI and Scripps Research as innovat…